Cabaletta Bio to Present at Upcoming Investor Conferences in October
PHILADELPHIA, Sept. 25, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery […]
Graybug Appoints Three New Members to its Board of Directors
REDWOOD CITY, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on […]
Rogers annonce une proposition d’investissement totalisant trois milliards de dollars au profit du Québec
Rogers annonce des investissements pour honorer l’héritage de Cogeco, accroître la connectivité en milieu rural, accélérer le déploiement de la […]
Rogers announces comprehensive $3 billion investment proposal to benefit Quebec
Rogers unveils investments to honour Cogeco’s legacy, expand rural connectivity, accelerate 5G coverage to 95% of Quebecers and create hundreds […]
Notice of third quarter 2020 results and conference call
Notice of third quarter 2020 results and conference call Luxembourg, September 25, 2020 – Millicom will announce its third quarter results […]
Collegium Appoints Rita Balice-Gordon to its Board of Directors
STOUGHTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being […]
The First of Long Island Corporation Announces 5.6% Increase in Quarterly Cash Dividend to $.19 per Share
GLEN HEAD, N.Y., Sept. 25, 2020 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC) announced today the […]
TSX News -
Bombardier celebrates unveiling of train design for India’s first semi-high-speed RRTS corridor
India’s first Regional Rapid Transit System (RRTS) will operate one of the fastest trains in India with a design speed […]
uniQure Announces Recommendations from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
LONDON, Sept. 25, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully […]
